Article
Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate Cancer
- Author:
- Alexander A. Harris, MD
- Mayuri Yasuda
- Megan S. Wu
- Jacqueline M. Deirmenjian
- Ahmer Farooq, DO
- Kristin G. Baldea, MD
- Robert Flanigan, MD
- Matthew M. Harkenrider, MD
- James S. Welsh, MD
- Abhishek A. Solanki, MD, MS
High-dose-rate brachytherapy as monotherapy is a well-tolerated treatment option for veterans with lowor intermediate-risk prostate cancer, with...